NasdaqGM:BBNXMedical Equipment
Does Beta Bionics (BBNX) Strong Q4 Sales Outlook Reshape Confidence in Its Long-Term Strategy?
Beta Bionics, Inc. has released preliminary, unaudited guidance indicating that net sales for the fourth quarter of 2025 are expected to be at least US$32.0 million, compared with US$20.4 million in the same period of 2024, and plans to report full results on February 17, 2026.
The company is also organizing in-person investor meetings in San Francisco in mid-January 2026, underscoring management’s effort to highlight recent operating momentum and engage more directly with the investment...